Inventor
WERTHMANN ULRIKE
DE17 patents
⚠️ This page may combine multiple inventors who share the name “WERTHMANN ULRIKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
5 patentsUS9233950B2Jan 12, 2016
Co-crystals and salts of CCR3-inhibitors
BOEHRINGER INGELHEIM INT10 citations81
US9802954B2Oct 31, 2017
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
BOEHRINGER INGELHEIM INT2 citations71
US10745411B2Aug 18, 2020
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
BOEHRINGER INGELHEIM INT1 citations70
US10919898B2Feb 16, 2021
Medical use of compound III
BOEHRINGER INGELHEIM INT0 citations56
US7638625B2Dec 29, 2009
Crystalline compounds
BOEHRINGER INGELHEIM INT2 citations56
CENTREXION THERAPEUTICS CORP
4 patentsUS11147814B2Oct 19, 2021
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p- tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate
CENTREXION THERAPEUTICS CORP5 citations83
US10568885B2Feb 25, 2020
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-citrate
CENTREXION THERAPEUTICS CORP6 citations83
US10213428B2Feb 26, 2019
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate
CENTREXION THERAPEUTICS CORP7 citations83
US12076321B2Sep 3, 2024
(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate
CENTREXION THERAPEUTICS CORP0 citations61